Guangdong Taiantang Pharmaceutical Co., Ltd.

    Guangdong Taiantang Pharmaceutical Co., Ltd.

    SSZSE:002433
    0.27
    CNY
    -0.03
    (-10.00%)
    Guangdong Taiantang Pharmaceutical Co., Ltd.
    SZSE:002433
    (Shenzhen Stock Exchange)

    Recent

    price

    0.27

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    TTM
    CNY
    0.81
    0.96
    0.9
    1.04
    1.29
    1.42
    1.98
    3.24
    4.04
    4.24
    4.28
    5.43
    4.83
    2.96
    0.84
    0.53
    0.43
    Revenue per Share
    0.13
    0.18
    0.16
    0.19
    0.22
    0.24
    0.3
    0.26
    0.32
    0.38
    0.35
    0.13
    0.03
    -1.05
    -1.26
    -2.88
    -2.81
    Basic EPS, GAAP
    -0.1
    0.06
    -0.63
    -0.57
    -0.51
    -0.87
    -0.75
    -2.23
    -0.9
    -0.78
    -0.11
    0.29
    -0.41
    1.06
    0.28
    -0.17
    -0.03
    Free Cash Flow per Basic Share
    0.01
    0.01
    0.01
    0.13
    0.05
    0.04
    0.07
    0.04
    0.06
    0.15
    0.17
    0.26
    0.2
    0.23
    0.13
    0.1
    0.07
    Dividend per Share
    0.45
    0.62
    0.76
    0.69
    0.99
    1.13
    1.98
    1.97
    2.18
    2.5
    2.79
    2.96
    2.97
    1.83
    -0.52
    -3.4
    -3.4
    Book Value per Share
    0.55
    0.71
    2.7
    1.97
    4.2
    3.29
    4.82
    5.11
    5.23
    5.54
    5.87
    6.25
    6.26
    5.57
    3.15
    0.25
    0.18
    Tangible Book Value per Share
    300
    299
    347
    401
    400
    554
    621
    731
    760
    764
    774
    739
    741
    765
    768
    767
    783
    Basic Weighted Avg Shares
    244
    288
    314
    417
    518
    785
    1,228
    2,372
    3,075
    3,239
    3,315
    4,013
    3,582
    2,264
    646
    410
    340
    Sales/Revenue/Turnover
    19.98
    23.96
    20.52
    20.41
    25.52
    21.59
    19.28
    9.72
    10.68
    12.84
    7.66
    6.16
    4.1
    -3.88
    -24.56
    -87.37
    -98.5
    Operating Margin (%)
    4
    5
    7
    14
    26
    37
    48
    51
    54
    76
    84
    96
    106
    131
    128
    107
    - -
    Depreciation Expense
    38
    54
    56
    74
    88
    133
    186
    190
    243
    290
    271
    96
    22
    -803
    -968
    -2,210
    -2,203
    Net Income, GAAP
    16.25
    19.67
    15.75
    15.3
    19.18
    12.26
    7.42
    11.94
    14.32
    16.91
    16.25
    17.96
    29.32
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    15.71
    18.69
    17.98
    17.77
    17
    16.93
    15.18
    8.02
    7.91
    8.97
    8.17
    2.39
    0.62
    -35.48
    -149.98
    -538.57
    -648.74
    Profit Margin (%)
    72
    100
    683
    402
    1,042
    832
    2,214
    2,626
    2,996
    2,378
    2,273
    2,050
    1,103
    2,468
    698
    -1,150
    -1,191
    Working Capital
    28
    32
    - -
    - -
    70
    73
    25
    7
    934
    1,025
    974
    998
    2
    29
    5
    75
    74
    LT Debt
    172
    221
    972
    1,010
    1,913
    2,042
    3,775
    4,510
    4,742
    5,027
    5,319
    5,397
    5,421
    4,584
    2,718
    396
    341
    Total Equity
    20.37
    21.3
    8.56
    6.43
    6.44
    6.72
    6.92
    4.49
    4.99
    5.07
    2.8
    2.66
    1.35
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    23.51
    25.44
    22.51
    18.73
    17.84
    17.36
    15.92
    10.91
    10.73
    9.55
    8.23
    4.44
    2.43
    - -
    - -
    - -
    - -
    Return on Capital (%)
    32.48
    33.58
    25.15
    27.37
    26.05
    25.99
    20.11
    14.24
    15.71
    16.3
    13.33
    4.42
    1.01
    -44.67
    - -
    - -
    -246.79
    Return on Common Equity (%)

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    ST Debt
    823
    1,177
    1,175
    LT Borrowings
    1
    - -
    - -
    LT Finance Leases
    - -
    75
    74
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    767
    767
    767
    Market Capitalization
    2,435
    1,820
    971

    Working Capital

    CNY

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    Total Current Assets
    3,428
    1,188
    1,144
    Cash, Cash Equivalents & STI
    34
    123
    94
    Accounts Receivable, Net
    286
    146
    156
    Inventories
    2,261
    510
    518
    Total Current Liabilities
    1,716
    2,338
    2,335
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    823
    1,177
    1,175
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -1.83%
    -27.94%
    -85.44%
    Free Cash Flow
    -111.05%
    -239.96%
    -158.81%
    Net Income, GAAP
    -362.4%
    -741.37%
    128.28%
    Sales/Revenue/Turnover
    5.25%
    -26.88%
    -36.43%
    Total Cash Common Dividend
    25.2%
    -5.65%
    -26.68%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    191
    318
    189
    -53
    646
    2023
    139
    122
    117
    32
    410
    2024
    69
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.05
    - -
    - -
    - -
    -1.26
    2023
    -0.08
    - -
    - -
    - -
    -2.88
    2024
    -0.07
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.03
    - -
    - -
    - -
    0.13
    2023
    0.03
    - -
    - -
    - -
    0.1
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business